Preclinical study demonstrates oral milk extracellular vesicles suppress tumors in colon tumor-bearing mice, highlighting safe gut-to-tumor chemotherapy delivery.
After oral administration of FDX@mEVs, it is observed that remarkable antitumor efficacy in colon tumor-bearing mice without adverse effects, such as body weight loss, liver/kidney dysfunction, and cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Jang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: